Brii Biosciences Limited announced unaudited consolidated earnings results for the six months ended June 30, 2021. For the six months, the company reported loss for the period of RMB 2,953,579,000 or RMB 14.86 basic per share against RMB 308,228,000 or RMB 1.63 basic per share a year ago.